In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2

This study, from Samantha Frank, MD, Division of Otolaryngology−Head and Neck Surgery, Department of Surgery, University of Connecticut School of Medicine, is among countless other studies that is intended to demonstrate the In-Vitro efficacy of a Povidone-Iodine Nasal Antiseptic in the fight against SARS-CoV-2.